Role of Sugammadex, Significance of its Dose and Timing for Rocuronium Induced Medically Refractory Anaphylactic Shock: A Case Report
Authors: Santhalakshmi Angappan*, Mohamed Fayed, Amna Shaikh, Ravnita Sharma, Nandak Choksi
*Corresponding Author: Santhalakshmi Angappan, Henry Ford Hospital, Detroit, Michigan, USA.
Henry Ford Hospital, Detroit, Michigan, USA.
Received Date: 24 March 2022
Accepted Date: 31 March 2022
Published Date: 6 April 2022
Citation: Angappan S, Fayed M, Shaikh A, Sharma R, Choksi N (2022) Role of Sugammadex, Significance of its Dose and Timing for Rocuronium Induced Medically Refractory Anaphylactic Shock: A Case Report. Ann Case Report 7: 815. DOI: https://doi.org/10.29011/25747754.100815
Rocuronium-induced anaphylaxis (RIA) during the perioperative period is a rare life-threatening event. Despite, the available evidence of sugammadex for RIA, there has been no standardized approach for the management of this critical scenario. Therefore, we propose a systematic approach for diagnosing and treating RIA. We, also present a case report of a medically refractory anaphylactic shock from rocuronium, which was effectively treated with sugammadex. Our literature review and experience suggest that sugammadex can be an effective treatment option for medically refractory rocuroniuminduced anaphylaxis, and thus should be part of the armamentarium for RIA.
Keywords: Sugammadex, Rocuronium, Life-threatening anaphylaxis, Perioperative anaphylaxis, Rocuronium-induced anaphylaxis, Sugammadex dosing and timing.
Copyright and Licensing: This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. With this license readers can share, distribute, download, even commercially, as long as the original source is properly cited. Read More.